Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 USD | -2.33% | +0.67% | -43.25% |
Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
Mar. 26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.58M |
---|---|---|---|---|---|
Net income 2023 * | -12M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on NeuBase Therapeutics, Inc.
1 day | -2.33% | ||
1 week | +0.67% | ||
Current month | -6.65% | ||
1 month | -59.22% | ||
3 months | -32.26% | ||
6 months | -40.93% | ||
Current year | -43.25% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Eric Richman
BRD | Director/Board Member | 63 | 19-07-11 |
Director/Board Member | 79 | 19-07-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.42 | -2.33% | 157,792 |
24-04-19 | 0.43 | -0.83% | 88,885 |
24-04-18 | 0.4336 | +3.26% | 47,877 |
24-04-17 | 0.4199 | +4.45% | 30,890 |
24-04-16 | 0.402 | -3.64% | 68,235 |
Delayed Quote Nasdaq, April 22, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-43.25% | 1.58M | |
-0.02% | 42.11B | |
+48.37% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- NBSE Stock